α-Lipoic acid — research review 2

...and this is where we really need to look at human evidence, not just cell studies or animal models. Take alpha-lipoic acid, for example. It’s a mitochondrial antioxidant, often touted for its anti-aging potential.

Right, and you see it in a lot of supplements. The theory is compelling – reducing oxidative stress in our cellular powerhouses, the mitochondria. But what does the human data actually say?

Well, that's where things get interesting, and often, less conclusive than the hype suggests. A meta-analysis published in Nutrition & Metabolism in 2018 looked at randomized controlled trials of alpha-lipoic acid on various metabolic markers in humans.

And what did they find?

They found some modest, statistically significant effects on things like fasting glucose and insulin sensitivity, particularly in individuals with metabolic disorders. But the magnitude of these effects wasn’t always clinically striking. Importantly, for general healthy aging or broad anti-aging benefits in the absence of specific conditions, the evidence is much weaker.

So, for someone just trying to live longer and healthier, not necessarily managing a pre-existing condition, the benefit isn't clearly established?

Exactly. Another review in Antioxidants in 2020 reiterated this – while it shows promise in specific disease contexts, particularly related to neuropathy, the evidence for its role as a general longevity intervention in healthy humans is largely unproven. We don't have large-scale, long-term trials demonstrating it extends lifespan or healthspan in healthy individuals. The null results, or lack of strong positive findings, are often overlooked when these molecules are marketed.

So, a lot more research is needed before we can make definitive claims for its role in healthy aging.